Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NovoSeven in Acute Intracerebral Haemorrhage
NCT01566786Phase 2Completed
- Sponsor
- Novo Nordisk
- Start
- Aug 2001
- Primary completion
- Oct 2002
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 9
01
Overview
A Phase 2 trial of coagulation factor VIIa in intracerebral hemorrhage (ICH), sponsored by Novo Nordisk. Started Aug 2001; status: completed.
02
Drugs
coagulation factor VIIa
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on NCT01566786.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01566786.